Mesenchymal stromal cells (MSCs), which reside within various tissues, are utilized in the engineering of cartilage tissue. Dexamethasone (DEX) -a synthetic glucocorticoid -is almost invariably applied to potentiate the growthfactor-induced chondrogenesis of MSCs in vitro, albeit that this effect has been experimentally demonstrated only for transforming-growth-factor-beta (TGF-β)-stimulated bone-marrow-derived MSCs. Clinically, systemic glucocorticoid therapy is associated with untoward side effects (e.g., bone loss and increased susceptibility to infection). Hence, the use of these agents should be avoided or limited. We hypothesize that the infl uence of DEX on the chondrogenesis of MSCs depends upon their tissue origin and microenvironment [absence or presence of an extracellular matrix (ECM)], as well as upon the nature of the growth factor. We investigated its effects upon the TGF-β1-and bone-morphogenetic-protein 2 (BMP-2)-induced chondrogenesis of MSCs as a function of tissue source (bone marrow vs. synovium) and microenvironment [cell aggregates (no ECM) vs. explants (presence of a natural ECM)]. In aggregates of bone-marrow-derived MSCs, DEX enhanced TGF-β1-induced chondrogenesis by an up-regulation of cartilaginous genes, but had little infl uence on the BMP-2-induced response. In aggregates of synovial MSCs, DEX exerted no remarkable effect on either TGF-β1-or BMP-2-induced chondrogenesis. In synovial explants, DEX inhibited BMP-2-induced chondrogenesis almost completely, but had little impact on the TGF-β1-induced response. Our data reveal that steroids are not indispensable for the chondrogenesis of MSCs in vitro. Their infl uence is context dependent (tissue source of the MSCs, their microenvironment and the nature of the growth factor). This fi nding has important implications for MSCbased approaches to cartilage repair.
Introduction
Owing to their self-renewal capacity, chondrogenic potential and accessibility, mesenchymal stromal cells (MSCs) are an attractive option for the engineering of cartilage tissue. MSCs were originally isolated from rat bone marrow (Friedenstein et al., 1966) , and they are known to reside within many mammalian tissues, such as synovium, trabecular bone, periosteum, articular cartilage, muscle and fat (De Bari et al., 2001b; Erickson et al., 2002; Nöth et al., 2002; Zuk et al., 2002; Alsalameh et al., 2004; Sinanan et al., 2004; Mastrogiacomo et al., 2005; De Bari et al., 2006) . Under appropriate stimulation conditions in vitro, MSCs can differentiate into several types of mesenchymal tissue, including bone, cartilage and fat.
In most in-vitro studies, dexamethasone (DEX) is used in conjunction with transforming growth factorbeta1 (TGF-β1), or one of its isoforms, to drive the differentiation of MSCs towards chondrogenesis. The chondrogenic effects of DEX were fi rst reported for lapine bone-marrow-derived MSCs . And, in a study with human bone-marrow-derived MSCs, TGF-ß1 induced chondrogenesis only in the presence of DEX . Subsequently, TGF-ß1 and DEX were concomitantly employed to elicit the chondrogenic differentiation of MSCs of diverse tissue origins, including fat (Erickson et al., 2002) , periosteum (De Bari et al., 2001a) , synovium (De Bari et al., 2001b) , trabecular bone (Nöth et al., 2002) and muscle (Mastrogiacomo et al., 2005) . However, the authors of the cited publications did not experimentally ascertain whether DEX was indeed necessary for the chondrogenesis of MSCs.
In a previous study, we demonstrated that BMP-2 could induce the chondrogenesis of bovine synovial explants in the absence of DEX . Indeed, in its presence, metachromasia of the extracellular matrix (ECM) did not occur after staining with Toluidine Blue. DEX also suppresses the BMP-2-induced chondrogenesis of isolated, alginate-cultured bovine and human synovial MSCs (Park et al., 2005; Kurth et al., 2007) . These fi ndings point to the existence of differences in the reactivity of synovial and bone-marrowderived MSCs to DEX. However, several issues await clarifi cation. In these previous studies of ours, the synovial MSCs were surrounded either by their native ECM (explant cultures) or by an artifi cial one (alginate). In the studies by other investigators, the bone-marrow-derived MSCs were cultured in the absence of an ECM, namely, under high-density conditions as pellets Yoo et al., 1998) . And apart from this variable, the www.ecmjournal.org N Shintani et al. Differential effects of DEX on chondrogenesis nature of the stimulating agent (BMP-2 or TGF-β1) also differed. The clinical application of steroid hormones such as DEX is associated not only with many benefi cial (e.g., antiinfl ammatory and immunosuppressive) effects, but also with numerous adverse ones (e.g., bone loss and increased susceptibility to infection) (Kleiman and Tuckermann, 2007) . In the context of clinical tissue engineering, these undesired side effects cannot be ignored. Since most of the untoward effects of DEX are associated with its systemic administration, a local delivery of the drug might offer a means of attenuating them (Na et al., 2006; Nuttelman et al., 2006) . Nevertheless, the unnecessary use of DEX should be avoided. We hypothesize that the potentiating effects of DEX on chondrogenesis depend not only upon the choice of the growth factor with which it is coupled, but also upon the tissue origin of the MSCs and their microenvironment (e.g., their numerical density and the nature of their ECM). Indeed, we conceive that, under appropriate conditions, it may even be possible to dispense with the agent altogether in tissue-engineering approaches to cartilage repair. It was the purpose of the present study to clarify this issue.
To defi ne the impact of the aforementioned parameters on the effects of DEX, we established the following setups: bovine synovial explants; aggregates of isolated bovine synovial MSCs; and aggregates of isolated bovine bone-marrow-derived MSCs. The fi rst case represents one that is close to the native state, namely, the MSCs are present at low numerical densities and are surrounded by their natural ECM. In the second and third cases, the MSCs are of different tissue origins and are cultured under high-density conditions in the absence of an ECM. In each set-up, either TGF-β1 or BMP-2 was used as the chondrogenic agent. Our study revealed the effects of DEX on the chondrogenesis of MSCs to be infl uenced by their microenvironment, their tissue source and the nature of the growth factor.
Materials and Methods

Preparation and culturing of synovial explants
Synovial tissue was harvested from the metacarpal joints of 4-month-old bovine calves within 24 h of slaughtering. After washing, the material was cut into slender strips (3-5 mm in width x 5-7 mm in length), the wet weights of which were measured under sterile conditions. The explants were sandwiched between two layers of agarose to prevent cell outgrowth . Each explant was covered with 1 mL of serum-free medium high-glucose DMEM (Invitrogen, Paisley, UK) containing 1 % ITS+ TM Premix (BD Biosciences, Bedford, MA, USA), 1 mM proline, ascorbic acid (50 μg/mL) and gentamycin (50 μg/mL)]. Chondrogenesis was induced by adding either human recombinant TGF-β1 (10 ng/mL; Peprotech, Rocky Hill, NJ) or BMP-2 200 ng/mL; a generous gift from Pfi zer (formerly Wyeth), New York City, NY, USA to the culture medium, in the absence or presence of DEX (100 nM; Sigma-Aldrich, St Louis, MO, USA). The growth factors and DEX were introduced every 2 days when the medium was changed. The medium was supplemented with fresh ascorbic acid (25 μg/mL) on a daily basis. The synovial explants were cultured for 2 or 4 weeks at 37 °C in a humidifi ed atmosphere containing 5 % CO 2 .
Isolation and expansion of synovial and bonemarrow-derived MSCs
Synovial tissue was harvested as described above. The material was minced and then digested fi rst (for 1 h) with 1 % pronase (Roche Diagnostics, Basel, Switzerland) in high-glucose DMEM containing gentamycin [DMEM/ gentamycin (50 μg/mL)] and then (overnight) with 0.14 % collagenase (Invitrogen) in DMEM/gentamycin . The supernatant was strained through a nylon fi lter with a pore diameter of 120 μm (Millipore AG, Volketswil, Switzerland) to remove undigested tissue. The cells were collected by centrifugation, washed twice and resuspended in growth medium (DMEM/gentamycin containing 10 % fetal bovine serum).
Bone-marrow cells were harvested from the metacarpal bones of 4-month-old bovine calves within 24 h of slaughtering. The marrow was removed and strained through a nylon fi lter with a pore diameter of 120 μm to remove adipose tissue. The cells were collected by centrifugation, washed twice and suspended in growth medium.
The cell suspensions were applied to 100-mm-diameter cell culture dishes and incubated at 37 °C in a humidifi ed atmosphere containing 5 % CO 2 . After 2-3 days, the medium was changed to remove non-adherent cells. The attached cells were further cultured until they had attained a state of near confl uence. For expansion, the near-confl uent cells were harvested by treatment with 0.25 % trypsin/1 mM EDTA and replated at a numerical density of 2-3x10 5 per dish (fi rst passage). The growth medium was replaced every 2-3 days until the cells had attained a state of near confl uence.
Micromass cultures
Aggregates of synovial and bone-marrow-derived MSCs were prepared by culturing them under micromass conditions, according to a modifi ed version of published protocols (De Bari et al., 2001b; Park et al., 2005; Shintani and Hunziker, 2007) . Specifi cally, the fi rst-passage MSCs were suspended at a numerical density of 2x10 7 per mL; 50-μL aliquots (~1 million cells per aggregate culture) were applied to 12-well tissue-culture plates, which were incubated for 4 h at 37 °C in a humidifi ed atmosphere containing 5 % CO 2 . 2 mL of serum-free medium were then added. Chondrogenesis was induced and the micromass cultures were maintained for 2 or 4 weeks as described above for synovial explants.
Histology and morphometry
After culturing, the synovial explants and the aggregates of synovial or bone-marrow-derived MSCs were chemically fi xed in phosphate-buffered saline (pH 7.4) containing 2 % formaldehyde and then embedded in paraffi n. 5-μm-thick sections of the embedded materials were prepared and stained with 1 % Toluidine Blue (pH 2.5) for the histological detection of sulfated proteoglycans within a N Shintani et al. Differential effects of DEX on chondrogenesis cartilaginous matrix (an indirect measure of chondrogenic differentiation). The sections were evaluated in a Nikon Eclipse E1000 light microscope using a DXM 1200F digital camera and Eclipsenet software (Nikon, Tokyo, Japan). The volume fraction of metachromasia in synovial explants was assessed morphometrically, as previously described .
Immunohistochemistry
Immunohistochemistry was performed on 5-μm-thick paraffi n-embedded sections through synovial explants and aggregates of synovial or bone-marrow-derived MSCs using murine monoclonal antibodies against type-II collagen (clone CII C1, Hybridoma Bank, Iowa City, IA, USA) and aggrecan (HAG7D4, Serotec, Oxford, UK), as previously described . Deparaffi nized sections were fi rst treated with hyaluronidase, then with 3 % skimmed bovine milk containing 1.5 % equine serum to block non-specific antibody reactivity, and finally with one of the primary antibodies (60 min at 37 °C). A biotinylated form of an equine, anti-murine secondary antibody (Vector Laboratories, Burlingame, CA, USA) was used to detect the antibodies against type-II collagen and aggrecan. Endogenous peroxidase activity was blocked with hydrogen peroxide. Immunoreactivity was enhanced by applying the avidin-biotin-peroxidase complex (Vector Laboratories). Cell nuclei were counterstained with hematoxylin. The sections were evaluated and photographed in a Nikon Eclipse E1000 light microscope.
Measurement of glycosaminoglycan (GAG)-content
Before culturing, the initial wet weight of each explant was measured under sterile conditions. After culturing, the tissue explants and the cell aggregates were digested (overnight at 60 °C) with 0.1 % papain and 0.1 % proteinase K in 1 mM CaCl 2 , which was buffered with 10 mM TRISHCl (pH 8) (Roche et al., 2001) . The DNA-content of the digests was measured spectrofl uorometrically using the High Sensitivity Quant-iTT TM DNA Assay Kit (Molecular Probes, Eugene, OR, USA). The weight of DNA (in ng) was expressed per mg of the initial wet explant weight or per MSC-aggregate. The glycosaminoglycan (GAG)-content of the digests was determined colorimetrically after treatment with 1,9-dimethylmethylene Blue (SERVA Electrophoresis, Heidelberg, Germany) (Farndale et al., 1986) . Chondroitin sulfate (Sigma-Aldrich) was used as a standard. The weight of GAGs (in μg) was expressed per μg of DNA, as well as per mg of the initial wet explant weight and per MSC aggregate.
RNA extraction, reverse transcription and real-time PCR After culturing, the tissue explants and the cell aggregates were stored in RNAlater TM (Qiagen, Hilden, Germany) at -70 °C. Isolation of the RNA, reverse transcription and realtime PCR were performed as previously described . The cultured samples were fi rst pulverized in a freezer mill and then dissolved in QIAzol™Lysis Reagent (Qiagen). RNA was isolated using the RNeasy Micro Kit (Qiagen). The RNA derived from each sample was reverse transcribed using the Reverse Transcription System (Promega, Madison, WI, USA) and then subjected to real-time PCR (Applied Biosystems 7900 instrument, Foster City, CA, USA). A calibrator was prepared from a mixture of the RNA that was isolated from the cartilage and synovium of bovine metacarpal joints. Primers and probes for bovine collagen types I, II, IX, X and XI, aggrecan, cartilage oligomeric matrix protein (COMP), Sox9 and 18S ribosomal RNA (rRNA) were generated as previously described . Specifi c primers and probes for bovine link protein [hyaluronan and proteoglycan link protein 1 (HAPLN1)] (forward primer: 5´-GAAGGCGCTGCAGTCCTAGC-3´; reverse primer: 5´-GGCACGCTCAGTTGTATGCTCT-3´; probe: 6-FAM-5´-CAGTGCGCTTCGTGGGTTTCCCA-3´-BHQ-1) were designed using Primer3 software (http://frodo.wi.mit. edu/primer3/). Gene expression was normalized to the level of 18S rRNA using the formula 2 -∆CT , where C T is the threshold cycle and ∆C T = C T (target gene) -C T (18S rRNA). For each gene, the normalized mRNA level in each sample (explant or aggregate) was calculated relative to that in the calibrator (mixture of uncultured cartilage and synovium) using the formula 2 -∆∆CT , where ∆∆C T = ∆C T (sample) -∆C T (calibrator).
Statistical analysis
Numerical data are represented as mean values together with the standard error of the mean (SEM). Comparisons between two sets of data were statistically evaluated by an analysis of variances (ANOVA). Comparisons between multiple groups were evaluated by applying Dunnett's multiple comparison test. Statistical analyses were performed using SPSS software, version 11. 04 (SPSS Inc., Chicago, IL, USA). Statistical signifi cance was set at a p-value of 0.05.
Results
DEX inhibits the growth-factor-induced deposition of a cartilage-like matrix in synovial explants: partially after stimulation with TGF-ß1, and almost completely after stimulation with BMP-2 To ascertain whether the effects of DEX on the chondrogenic differentiation of synovial explants depends upon the nature of the growth factor, explants were exposed to either TGF-β1 (10 ng/mL) or BMP-2 (200 ng/mL), in the absence or presence of DEX (100 nM), for 2 or 4 weeks. In the absence of a growth factor, the ECM of synovial explants manifested no discernible metachromasia after staining with Toluidine Blue, irrespective of the absence or presence of DEX (Fig. 1A) . After stimulation with TGF-β1 for 4 weeks in the absence of DEX, the ECM of synovial explants manifested intense metachromasia (Fig. 1A) . When DEX was included in the culture medium, TGF-β1 induced weak metachromasia (Fig. 1A ). After stimulation with BMP-2 for 4 weeks in the absence of DEX, the ECM of synovial explants manifested intense metachromasia and the cells had differentiated into chondrocytes, which were surrounded by pericellular lacunae (Fig. 1A) .
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When DEX was included in the culture medium, BMP-2 failed to induce either metachromasia (Fig. 1A ) or cell differentiation ( Fig. 1 A,B) . Immunohistochemistry for aggrecan and type-II collagen was also performed. In the absence of a growth factor, neither aggrecan nor type-II collagen was detected in synovial explants, irrespective of the absence or presence of DEX (Fig. 1B ). After stimulation with TGF-β1 in the absence of DEX, immunostaining for aggrecan was intense in synovial explants (Fig. 1B) . DEX suppressed the TGF-β1-stimulated deposition of aggrecan in synovial explants. Stimulation with TGF-β1 in the absence of DEX led to weak immunostaining for type-II collagen in peripheral portions of the synovial explants. DEX suppressed the TGF-β1-stimulated deposition of type-II collagen in synovial explants. After stimulation with BMP-2 in the absence of DEX, aggrecan and type-II collagen were deposited in synovial explants (Fig. 1B) . DEX suppressed the BMP-2-stimulated deposition of these proteins (Fig.  1B) .
The GAG-content of synovial explants was quantifi ed histochemically by measuring the volume fraction of metachromasia and biochemically (in tissue digests) using the dimethylmethylene-Blue assay. After 4 weeks of culturing, the TGF-β1-induced volume fraction of metachromasia was higher in the absence than in the presence of DEX (Fig. 2A) ; the GAG-contents per μg of DNA and per mg of the initial wet explant weight were also higher, but not signifi cantly so (Fig. 2B,C) . Likewise after 4 weeks of culturing, the BMP-2-induced volume fraction of metachromasia ( Fig. 2A ) and the GAG-content (Fig. 2B ,C) were both signifi cantly higher in the absence than in the presence of DEX. To assess the effect of DEX on cell number, the weight of DNA (measured at the end of the culturing period) was expressed per mg of the initial wet explant weight (Fig. 2D ). After stimulation for 4 weeks with either TGF-β1 or BMP-2, the DNA-content per mg of the initial wet explant weight was not signifi cantly infl uenced by the absence or presence of DEX. Yoo et al., 1998) , but suppresses the TGF-β1-induced accumulation of GAGs in synovial explants (as described above). This seemingly paradoxical response to DEX using the same growth factor could be attributable to a difference in either the microenvironment of the MSCs or their tissue origin. To clarify this issue, bone-marrowderived and synovial MSCs were cultured under the same high-density conditions as aggregates. Initially, the isolated MSCs were grown as monolayers in serum-containing medium (passage 0). Under these culturing conditions, both the synovial and the bone-marrow-derived MSCs had a fi broblast-like appearance and protruded irregularly branched cytoplasmic processes (Fig. 3A) . After the fi rst passage, the synovial MSCs had a similar shape but were somewhat larger; the bone-marrow-derived MSCs were much broader and the cytoplasmic processes had undergone considerable retraction (Fig. 3A) .
The fi rst-passage MSCs were plated as aggregates. Under these micromass-culturing conditions, the synovial and bone-marrow-derived MSCs behaved differently.
The aggregates of synovial MSCs formed disc-like units which maintained their shape during the entire 4-week culturing period (although discs cultured with a growth factor occasionally detached from the plates and shrank a little) (Fig. 3B: left) . On the other hand, aggregates of bone-marrow-derived MSCs detached from the plates within a few days of culturing and formed spherical units, irrespective of the absence or presence of DEX ( Fig. 3B : right). However, in the absence of DEX, the aggregates of bone-marrow-derived MSCs shrank so considerably during the course of time as to render necessary a termination of the culturing period after 2 weeks for the purpose of quantitative analysis.
In the absence of a growth factor, synovial MSCaggregates manifested no metachromasia after 4 weeks of culturing, irrespective of the absence or presence of DEX (Fig. 4A ). In the absence of DEX, both TGF-β1 and BMP-2 induced limited metachromatic staining of the ECM after 2 weeks of culturing, and the response was heightened after 4 weeks in both cases (Fig. 4A) . Metachromatic staining was not signifi cantly enhanced in the presence of DEX (Fig. 4A ). In the absence of a growth factor, bone-marrow-derived MSC-aggregates manifested weak metachromatic staining of the ECM after 2 weeks of culturing, irrespective of the absence or presence of DEX (Fig. 4A ). In the absence of DEX, neither TGF-ß1 nor Differential effects of DEX on chondrogenesis BMP-2 enhanced this response. In the presence of DEX, TGF-ß1 induced a substantial increase in the intensity of metachromatic staining, whereas BMP-2 elicited a minimal one (Fig. 4A ).
Immunohistochemistry for aggrecan and type-II collagen was performed on aggregates of isolated synovial MSCs that had been cultured for 4 weeks and on aggregates of bone-marrow-derived MSCs that had been cultured for 2 weeks. In the absence of a growth factor, aggregates of synovial MSCs manifested no immunoreactivity for either aggrecan or type-II collagen, irrespective of the absence or presence of DEX (Fig. 4B : left, top row). After stimulation with TGF-β1 in the absence of DEX, aggregates of synovial MSCs manifested moderate immunostaining for aggrecan and weak immunoreactivity for type-II collagen ( Fig. 4B : left, middle row). DEX enhanced the TGF-β1-stimulated deposition of aggrecan but not that of type-II collagen. After stimulation with BMP-2 in the absence of DEX, aggregates of synovial MSCs manifested moderate immunoreactivity for both aggrecan and type-II collagen (Fig. 4B: left, bottom row) . DEX enhanced the BMP-2-stimulated deposition of aggrecan but not that of type-II collagen.
In the absence of a growth factor and DEX, aggregates of bone-marrow-derived MSCs manifested very weak immunostaining for aggrecan but none for type-II collagen ( Fig. 4B : right, top row). DEX enhanced the deposition of aggrecan but did not lead to the accumulation of type-II collagen. After stimulation with TGF-β1 in the absence of DEX, aggregates of bone-marrow-derived MSCs manifested very weak immunoreactivity for aggrecan and almost none for type-II collagen (Fig. 4B : right, middle row). DEX enhanced the TGF-ß1-stimulated deposition of both aggrecan and type-II collagen. After stimulation with BMP-2 in the absence of DEX, aggregates of bone-marrow-derived MSCs manifested moderate immunoreactivity for aggrecan but almost none for type-II collagen (Fig. 4B : right, bottom row). DEX enhanced the BMP-2-stimulated deposition of both aggrecan and type-II collagen. We also quantifi ed the GAG-content of MSC-aggregates biochemically. In aggregates of isolated synovial MSCs, DEX failed to enhance the GAG-content 
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per μg of DNA, irrespective of the absence or presence of a growth factor ( Fig. 5A:a) . However, it signifi cantly decreased the GAG-content per aggregate after stimulation with TGF-β1 for 4 weeks ( Fig. 5A:b) . The latter effect was attributable to a decrease in the total amount of DNA per aggregate (Fig. 5A:c) . In aggregates of bone-marrowderived MSCs that had been stimulated with TGF-β1 for 2 weeks, DEX tended to enhance the GAG-content, both per μg of DNA (signifi cantly) ( Fig. 5B :a) and per aggregate (not signifi cantly) (Fig. 5B:b) . The total amount of DNA per aggregate of bone-marrow-derived MSCs was not signifi cantly infl uenced by the absence or presence of DEX ( Fig. 5B:c) .
DEX suppresses the expression of a panel of cartilaginous genes in synovial explants but not in aggregates of isolated synovial MSCs
To improve our understanding of the effects of DEX on the chondrogenic differentiation of synovial MSCs, we monitored the expression levels of a panel of cartilaginous genes in synovial explants and aggregates of isolated synovial MSCs after stimulation with either TGF-β1 or BMP-2 for 2 or 4 weeks (Fig. 6A,B) . In synovial explants that had been incubated in the absence of DEX, stimulation with TGF-β1 led to signifi cant increases in the geneexpression levels of type-XI collagen, aggrecan, COMP, Sox9 and link protein after 2 weeks of culturing, and to further increases after 4 weeks. In aggregates of isolated synovial MSCs, stimulation with TGF-β1 led to increases in the expression levels of the same genes after 2 weeks of culturing; by the 4 th week, the expression levels had either decreased or plateaued.
In synovial explants that had been incubated in the absence of DEX, stimulation with BMP-2 led to signifi cant increases in the gene-expression levels of collagen types II and IX, aggrecan, Sox9 and link protein after 2 weeks of culturing, and to further increases after 4 weeks (Fig. 6A,B) . In aggregates of isolated synovial MSCs, stimulation with BMP-2 led to increases in the expression levels of the same genes after 2 weeks of culturing; after In synovial explants that had been incubated in the presence of DEX, stimulation with TGF-β1 led to significant increases in the gene-expression levels of collagen types I, X and XI, aggrecan and COMP after 2 weeks of culturing. After 4 weeks, further increases in the expression levels of all of these genes except type-XI collagen (no change) were manifested. In aggregates of isolated synovial MSCs, stimulation with TGF-β1 evoked a signifi cant increase in the gene-expression level of COMP alone; by the 4 th week, the level had decreased. In synovial explants that had been incubated in the presence of DEX, stimulation with BMP-2 led to signifi cant increases in the gene-expression levels of link protein (after 2 weeks) and aggrecan (after 4 weeks). In aggregates of isolated synovial MSCs, stimulation with BMP-2 led to signifi cant increases in the gene-expression levels of collagen types II, IX, X and XI, aggrecan and link protein after 2 weeks of culturing. After 4 weeks, the gene-expression levels of collagen types II, IX and XI and link protein had increased further.
We also compared the gene expression levels in the synovial explants with those in the aggregates of synovial MSCs (Fig. 6 ). In the absence of a growth factor and DEX, the gene expression levels of type-X collagen (4 weeks), aggrecan (2 and 4 weeks), COMP (2 weeks) and link protein (4 weeks) were signifi cantly lower, and that of Sox9 (2 weeks) was signifi cantly higher in aggregates than in explants. After stimulation with TGF-ß1 in the absence of DEX, the gene-expression levels of collagen types II (4 weeks), IX (2 weeks) and X (2 and 4 weeks) were signifi cantly lower, and those of type-XI collagen (2 weeks) and Sox9 (2 weeks) signifi cantly higher in aggregates 
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than in explants. After stimulation with BMP-2 in the absence of DEX, the gene-expression levels of collagen types I (4 weeks) and X (4 weeks) were signifi cantly lower, and those of type-XI collagen (2 weeks), aggrecan (2 weeks) and Sox9 (2 and 4 weeks) signifi cantly higher in aggregates than in explants. In the absence of a growth factor and the presence of DEX, the gene-expression levels of type-X collagen (2 and 4 weeks), aggrecan (4 weeks) and link protein (2 and 4 weeks) were signifi cantly lower in aggregates than in explants. After stimulation with TGF-β1 in the presence of DEX, the gene-expression levels of collagen types I (4 weeks), II (4 weeks) and X (2 and 4 weeks) were signifi cantly lower, and that of Sox9 (2 and 4 weeks) was signifi cantly higher in aggregates than in explants. After stimulation with BMP-2 in the presence of DEX, the gene-expression level of type-X collagen (4 weeks) was signifi cantly lower, and those of collagen types II (2 and 4 weeks), IX (2 and 4 weeks) and XI (2 and 4 weeks), aggrecan (2 and 4 weeks), COMP (2 weeks), Sox 9 (2 weeks) and link protein (2 weeks) were signifi cantly higher in aggregates than in explants.
To gain a clearer idea of the infl uence of DEX on the up-and down-regulation of each gene, the data in Fig. 6 were represented as ratios of the expression levels in the presence to those in the absence of DEX (Fig. 7) . DEX signifi cantly up-and down-regulated gene expression even in unstimulated synovial explants and aggregates of isolated synovial MSCs. In synovial explants, DEX regulated gene expression according to the nature of the growth factor. After stimulation with TGF-β1, DEX signifi cantly down-regulated the genes for collagen types II and XI and link protein after 2 weeks of culturing, and that for type-XI collagen after 4 weeks. However, it signifi cantly up-regulated the gene for COMP after 2 weeks of culturing, and that for type-X collagen after 4 weeks. After stimulation with BMP-2, DEX signifi cantly down-regulated the genes for collagen types I, II, IX and XI, aggrecan, COMP and link protein after 2 weeks of culturing, and those for collagen types I, II, IX and XI after 4 weeks. Only the gene for Sox9 was up-regulated (after 2 weeks of culturing). In aggregates of isolated synovial MSCs, DEX down-regulated the expression only of the type-XI-collagen gene, and irrespective of whether they had been stimulated with TGF-β1 or BMP-2. It signifi cantly up-regulated the gene for COMP only after stimulation with TGF-β1 for 2 weeks, and that for aggrecan only after stimulation with BMP-2 for 4 weeks.
DEX enhances the expression of a panel of cartilaginous genes in bone-marrow-derived MSCs only after stimulation with TGF-ß1; not after stimulation with BMP-2
In the present section, we address the chondrogenic response of bone-marrow-derived MSC-aggregates to DEX, TGF-β1 and BMP-2 at the gene-expression level. In the absence of DEX, TGF-β1 and BMP-2 suppressed the expression of the type-I-collagen gene and enhanced that of the Sox9 gene (Fig. 8A) . However, neither TGF-β1 nor BMP-2 enhanced the expression of any of the genes that serve as markers for a cartilaginous ECM. In the presence of DEX, TGF-β1 stimulated increases in the gene-expression levels of collagen types II, IX and XI, aggrecan, COMP and link protein; BMP-2 exerted no effect on the expression levels of these genes. In Fig. 8B , the data for each gene are represented as ratios of the expression levels in the presence to those in the absence of DEX. In unstimulated aggregates of bone-marrow-derived MSCs, DEX down-regulated the gene for type-I collagen and upregulated those for collagen types II and X, Sox9 and link protein. After stimulation with TGF-ß1, DEX up-regulated the genes for collagen types II, IX and XI, aggrecan, Sox9 and link protein. After stimulation with BMP-2, DEX upregulated only the genes for Sox9 and link protein.
Discussion
Glucocorticoids are known to have variable effects on cell activities. They have been shown not only to inhibit the proliferation and differentiation of osteoblasts (Weinstein et al., 1998; Pereira et al., 2001) , but also to promote the latter process, as well as to enhance alkaline-phosphatase activity and mineralization (Aubin, 1999; Jorgensen et al., 2004; Purpura et al., 2004) . Likewise in the case of chondrocytes, glucocorticoids have been shown not only to promote the differentiation of these cells (Quarto et al., 1992) and their elaboration of a cartilaginous matrix (Kato and Gospodarowicz, 1985; Takano et al., 1985; Sekiya et al., 2001) , but also to inhibit their growth and their expression of type-II collagen (Miyazaki et al., 2000) . Published data are thus confl icting, and the actions of glucocorticoids are ill-defi ned. DEX, a synthetic glucocorticoid, is frequently used to promote the chondrogenesis of MSCs in vitro. However, it has not been hitherto recognized that the effects of DEX on this process are context dependent. In the present study, the effects of DEX on the chondrogenesis of MSCs were shown to depend upon their microenvironment, their tissue origin and the nature of the growth factor (TGF-β1 or BMP-2).
DEX suppresses the chondrogenic differentiation of MSCs in synovial explants to a degree that depends upon the nature of the growth factor
Previously, we have shown that the BMP-2-induced metachromasia of bovine synovial explants occurred only when DEX was excluded from the culturing medium . In the present study, we have demonstrated that DEX almost completely inhibits the BMP-2-induced chondrogenic differentiation of synovial explants as gauged by the volume fraction of metachromasia and the GAG-content. We have further shown that the effect of DEX is achieved via a down-regulation of the genes for collagen types I, II, IX and XI, COMP and link protein, as well as that for aggrecan (responsible for metachromasia). Not surprisingly therefore, dramatic decreases in the protein levels of type-II collagen and aggrecan were demonstrated immunohistochemically. Interestingly, in contrast to its effect on other marker genes for a cartilaginous matrix, DEX up-regulated the gene for Sox9 -a transcription factor that is crucial for chondrogenesis (Akiyama, 2008) and particularly for the expression of the genes for collagen types II, IX and XI www.ecmjournal.org N Shintani et al. Differential effects of DEX on chondrogenesis and aggrecan (Bi et al., 1999) . Contradictory fi ndings relating to the gene expression of type-II collagen and Sox9 have been documented also by other investigators. Using chondrocytes that were derived from adult human articular cartilage, Aigner et al. demonstrated the absence of a correlation between the gene-expression levels of Sox9 and type-II collagen, thereby indicating that the expression of the former gene does not alone suffi ce for that of the latter (Aigner et al., 2003) . Our own data suggest that DEX may regulate the gene expression not only of type-II collagen but also that of collagen types IX and XI and aggrecan via a pathway involving other factors than Sox9. Whilst DEX inhibits the BMP-2-induced chondrogenic differentiation of synovial explants, it promotes the TGF-β-induced chondrogenesis of bone-marrow-derived MSCs Yoo et al., 1998; Derfoul et al., 2006) . We thus wished to ascertain whether DEX likewise inhibits the TGF-β1 induced chondrogenesis of synovial explants. Although TGF-β1-induced the accumulation of GAGs in synovial explants that were cultured in the absence of DEX, type-II collagen was deposited in smaller quantities than after stimulation with BMP-2, as gauged immunohistochemically. But, unlike BMP-2, TGF-β1 was still capable of inducing metachromasia of the ECM when DEX was present, albeit to a lower degree than when it was absent. Furthermore, DEX down-regulated fewer genes in synovial explants that had been stimulated with TGF-β1 rather than with BMP-2. DEX thus suppresses both the TGF-β1-and BMP-2-induced chondrogenesis of MSCs in synovial explants, but to a lesser degree in the former case than in the latter.
The effects of DEX on the chondrogenic differentiation of synovial MSCs are infl uenced by their microenvironment, whereas those of the growth factors are not To evaluate the infl uence of the microenvironment on the effects of DEX, we compared its action on the TGF-β1-and BMP-2-stimulated chondrogenic differentiation of synovial explants and aggregates of isolated synovial MSCs. In contrast to its inhibitory effect on the chondrogenic differentiation of synovial explants, DEX had no infl uence on either the TGF-β1-or BMP-2-induced metachromaticstaining properties of aggregates of isolated synovial MSCs, and it even enhanced immunostaining for aggrecan after exposure to these growth factors. Similarly, it did not decrease either the TGF-β1-or BMP-2-induced increase in GAG content per μg of DNA. However, it signifi cantly decreased the TGF-β1-induced increase in GAG-content per aggregate. We suspect that the latter fi nding refl ects a loss of cells during culturing, since, after stimulation for 4 weeks with TGF-ß1, the amount of DNA per aggregate was lower in the presence than in the absence of DEX.
The effects of DEX on synovial explants and aggregates of isolated synovial MSCs also differed at the gene-expression level. In aggregates of isolated synovial MSCs, DEX signifi cantly down-regulated only the type-XI-collagen gene after stimulation with TGF-β1 or BMP-2. Under the infl uence of BMP-2, it up-regulated the aggrecan gene, which accords with the immunohistochemical fi nding. However, after stimulation with TGF-β1, it failed to up-regulate the aggrecan gene, which is at variance with the immunohistochemical fi nding. Aggrecan is known to bind to other matrix proteins, such as cartilage matrix protein, link protein and COMP (Neame and Barry, 1993; Hauser et al., 1996; Chen et al., 2007) . We thus speculate that a TGF-β1-induced up-regulation of other genes may promote the deposition of aggrecan in aggregates of isolated synovial MSCs.
Our data afford evidence that the microenvironment of synovial MSCs infl uences their response to DEX. As yet, we cannot account for this fi nding. Conceivably, their isolation and expansion may impact their chondrogenic responsiveness. Under the same stimulation conditions, the expression levels of several genes (type-X collagen, aggrecan, COMP and link protein in the absence of a growth factor; collagen types II, IX, X and XI and Sox9 after exposure to TGF-β1; collagen types I, X and XI, aggrecan and Sox9 after exposure to BMP-2) differed signifi cantly between synovial explants and aggregates of synovial MSCs (Fig. 6 ). For example, the gene-expression levels of Sox9 (2 weeks) were consistently higher in aggregates, whereas those of type-X collagen (4 weeks) were consistently higher in explants. However, in the absence of DEX, their chondrogenic responsiveness either to TGF-ß1 or to BMP-2 did not differ: in both synovial explants and aggregates of synovial MSCs, the geneexpression levels of collagen types II, IX and X, Sox9 and link protein were consistently higher after stimulation with BMP-2 than after exposure to TGF-β1, whereas those of COMP and type-XI collagen were consistently higher after stimulation with TGF-β1 than after exposure to BMP-2 (Fig. 6) . Only the responsiveness to DEX appears to be impacted by the microenvironment of the synovial MSCs. Furthermore, we have previously demonstrated that when isolated synovial MSCs are seeded at low numerical densities within a matrix (alginate), DEX completely suppresses their BMP-2-induced chondrogenesis (Park et al., 2005; Kurth et al., 2007) , as it does the BMP-2-induced chondrogenesis of synovial explants. These fi ndings indicate that it is indeed the microenvironment (including the numerical density of cells) that infl uences the responsiveness of synovial MSCs to DEX, and not the isolation and expansion procedures per se.
We suspect that the microenvironment infl uences the effect of DEX on the chondrogenesis not only of synovial but also of bone-marrow-derived MSCs. This tenet is supported by the fi ndings of Buxton et al. (Buxton et al., 2011) . These authors demonstrated that hydrogelcultured MSCs of bone-marrow origin could be induced to undergo chondrogenesis in the absence of DEX. A similar phenomenon has been reported for chondrocytes: whilst glucocorticoids promote the differentiation of isolated chondrocytes (Quarto et al., 1992) and stimulate their synthesis of proteoglycans (Kato and Gospodarowicz, 1985; Takano et al., 1985) , they suppress the growth of cartilage explants, as well as their synthesis of proteoglycans and collagen (Barrett et al., 1966; Tessler and Salmon, 1975; Silbermann et al., 1987) .
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The chondrogenic effects not only of DEX but also of growth factors are infl uenced by the tissue source of the MSCs In aggregates of isolated synovial MSCs that were cultured without DEX, TGF-β1 stimulated a considerable increase in the deposition of GAGs but only a barely detectable one in that of type-II collagen. DEX enhanced neither the accumulation of GAGs (although an increase in the aggrecan-content was demonstrated immunohistochemically) nor the deposition of type-II collagen. In other studies using bone-marrow-derived MSCs Yoo et al., 1998; Derfoul et al., 2006) , DEX enhanced the deposition of both GAGs and type-II collagen. To ascertain whether the responsiveness of MSCs to DEX is infl uenced by their tissue origin, bone-marrow-derived MSCs were cultured under the same conditions as isolated synovial MSCs, namely, as aggregates. Consistent with existing data Yoo et al., 1998; Derfoul et al., 2006) , DEX greatly enhanced the TGF-β1-induced chondrogenesis of aggregates of bovine bone-marrow-derived MSCs, as evidenced by the accumulation of GAGs (histochemical and biochemical determinations) and by the immunohistochemically demonstrated deposition of type-II collagen and aggrecan. DEX also up-regulated the genes for collagen types II, IX and XI, aggrecan and link protein. Hence, the effects of DEX on the TGF-β1 induced chondrogenesis of MSCs are clearly infl uenced by their tissue source. Many researchers have shown BMPs to be capable of inducing the chondrogenesis of bone-marrow-derived MSCs (Majumdar et al., 2001; Schmitt et al., 2003; Sekiya et al., 2005; Neumann et al., 2007) . In these previous studies, DEX was unquestioningly introduced into the culture medium, following the precedent for TGF-β1-induced chondrogenesis. However, whether DEX is really necessary for the BMP-2-induced chondrogenesis of bone-marrow-derived MSCs has never been established. In the present study, DEX did indeed enhance the BMP-2-induced chondrogenesis of bone-marrow-derived MSCs. However, its effect was much weaker under the infl uence of BMP-2 than under that of TGF-β1.
Incidentally, the present study has revealed synovial and bone-marrow-derived MSCs to manifest different aggregation behaviors: synovial MSCs formed disc-like units, whereas bone-marrow-derived MSCs formed spherical ones, which were smaller (Fig. 3B ) and contained lesser amounts of DNA and GAGs per aggregate (Fig.  5A :b,c and Fig. 5B:b,c) . The bone-marrow-derived MSC-aggregates thus contained few surviving cells. After stimulation for 3 weeks with TGF-β3 and BMP-2 in the presence of DEX, Sakaguchi et al. compared the chondrogenic potentials of pelleted synovial and bonemarrow-derived MSCs on the basis of their wet weights as well as their histology (Sakaguchi et al., 2005) . In a later study, they also monitored the gene-expression levels of type-II collagen, as well as the amounts of chondroitin sulfate and hyaluronan per pellet (Yoshimura et al., 2007) . Since the fi nal wet weights of the pelleted synovial MSCs were found to be greater than those of the bone-marrow-derived ones in the earlier study (Sakaguchi et al., 2005) , the authors concluded that the former had a higher chondrogenic potential per pellet than the latter. In a previous study of ours, the weights of synovial explants did indeed accord with the degree of chondrogenesis . However, in the present study, aggregates of viable bone-marrow-derived MSCs that had been stimulated with TGF-β1 in the presence of DEX deposited greater quantities of type-II collagen than did those of viable synovial MSCs that had been stimulated with BMP-2 in the absence of DEX (Fig. 4) , even though aggregates of bone-marrow-derived MSCs were smaller than those of synovial MSCs (Fig. 3B ). This finding indicates that when the MSCs are derived from different tissue sources, the size of an aggregate does not refl ect the degree of chondrogenic differentiation per cell. This parameter will be infl uenced by the number of surviving cells, which could be tissue-source dependent. Whether this tenet holds true for pellet cultures (Sakaguchi et al., 2005) , that is to say, for compacted masses of cells that are generated by centrifugation, is not known. But, at least for micromass cultures, that is to say, for high-density masses of cells that are formed from suspensions by spontaneous sedimentation under the force of gravity, a size (weight) comparison between MSC-aggregates from different tissue sources is not alone a reliable indicator of their relative chondrogenic potentials.
Not only DEX, but also the nature of the growth factor influences the chondrogenic differentiation of MSCs of diverse tissue origins. TGF-β1 alone (without DEX) stimulated barely detectable increases in the GAG-content and expression levels of cartilaginous genes in aggregates of bone-marrow-derived MSCs, but substantial ones in aggregates of synovial MSCs. Likewise, BMP-2 alone failed to stimulate either the deposition of type-II collagen or the expression of cartilaginous genes to a signifi cant degree in aggregates of bone-marrow-derived MSCs, but did so in aggregates of synovial MSCs.
Putative mechanisms that might account for the wayward effects of DEX At present, we can offer no plausible explanation for the variable effects of DEX on the chondrogenic differentiation of MSCs. The physiological and pharmacological actions of glucocorticoids (including synthetic ones) are predominantly mediated via the ubiquitously-expressed glucocorticoid receptor (GR) (Chrousos and Kino, 2005) . To date, two isotypes have been identifi ed: GR and GRβ (Bamberger et al., 1995) . GRß is a dominant inhibitor of GR, and changes in the cellular GR-to-GRβ ratio can infl uence sensitization and resistance to glucocorticoids (Gross and Cidlowski, 2008) . Human bone-marrowderived MSCs have been reported to express both GR and GRβ (Derfoul et al., 2006) . Furthermore, over expression of GRß has been shown to inhibit the DEXand TGF-ß-induced up-regulation of reporter activity for the type-II-collagen-gene promoter. We suspect that the distribution of GR-isoforms on MSCs may be infl uenced by their microenvironment and tissue origin, as well as by the nature of the growth factor to which they are exposed, and that these differences in GR-isoform topography may N Shintani et al. Differential effects of DEX on chondrogenesis partially account for the wayward effects of DEX on their chondrogenic differentiation. The role played by the microenvironment in regulating the infl uence of DEX on chondrogenesis (perhaps by modulating the expression of the GRs) is as yet unknown. Components of the ECM not only afford structural support for the cells but also generate signals for the regulation of their adhesion, differentiation, spreading and migration (Hynes, 2009) . ECM signals are transduced to the cell interior after binding to transmembrane receptors: the integrins (Hynes, 2002) , which also function in cell-cell contacts and in cross talk with growth factors (Prowse et al., 2011) . It is thus conceivable that integrin-mediated interactions with ECM components regulate the infl uence of DEX on the chondrogenic differentiation of MSCs. If so, then the response would be expected to vary according to the composition of the cellular microenvironment. The ECM also acts as a reservoir for growth factors (Hynes, 2009) . It can bind and sequester these, possibly affecting their bioavailability and activity. ECM-bound growth factors can be differentially released to establish local concentration gradients, which may be important for patterning during embryonic development. We do not know whether DEX can likewise bind to components of the ECM, but the binding and sequestration of the growth factors could partially account for its different effects on the TGF-β1-and BMP-2-induced chondrogenesis of MSCs in synovial explants (presence of a natural ECM) and aggregates (absence of a natural ECM).
We cannot as yet explain how DEX differentially modulates the TGF-β1-and BMP-2-induced chondrogenesis of MSCs at the signal-transduction level. TGF-βs and BMPs are members of the TGF-β superfamily. They bind to specifi c type-II receptors on cell surfaces, thereby triggering the recruitment of type-I receptors and the cascade of events that lead to the phosphorylation of specifi c receptor-regulated Smads (R-Smads) (Miyazono et al., 2001) . TGF-ß-signaling is mediated by Smads 2 and 3, and BMP-signaling by Smads 1, 5 and 8 (Miyazono et al., 2001) . The simultaneous deletion of Smads 1 and Fig. 9 . Scheme summarizing the wayward effects of DEX on the TGF-β-or BMP-2-induced chondrogenic differentiation of synovial explants, aggregates of synovial MSCs and aggregates of bone-marrow-derived MSCs. Relative differences in the GAG-content (histochemical and biochemical analyses), and in the deposited quantities of aggrecan and type-II collagen (Col2) (immunohistochemical analysis), are indicated as follows: ">": higher on the left of the arrowhead; "<": higher on the right of the arrowhead; "=": equal; ">>": much higher on the left of the arrowhead; "<<": much higher on the right of the arrowheads. N Shintani et al. Differential effects of DEX on chondrogenesis 5 in mice leads to severe chondrodysplasia (Retting et al., 2009) . This fi nding indicates that BMP-signaling is essential for chondrogenesis in vivo. On the other hand, deletion of Smad3 enhances the terminal differentiation of chondrocytes and leads to an osteoarthritic degeneration of articular cartilage (Yang et al., 2001) . These fi ndings reveal the importance of TGF-ß-signaling in the regulation of terminal chondrocytic hypertrophy and in the maintenance of articular cartilage. However, TGF-β does not appear to be essential for chondrogenesis per se. Mice in which the genes for TGF-β1 and TGF-β3, or that for TGF-β2, have been deleted develop a normal skeleton; their limbs manifest only minor skeletal defects (Pryce et al., 2009; Sanford et al., 1997) . Likewise in the present study, the chondrogenic potential of TGF-β1 was lower than that of BMP-2 on the basis of the immunohistochemical fi ndings, although the capacity of the two growth factors to stimulate the accumulation of GAGs (detected biochemically) did not differ signifi cantly. In synovial explants and aggregates of synovial MSCs, BMP-2 stimulated a considerable increase in the deposition of type-II collagen, whereas TGF-β1 elicited a barely detectable one, irrespective of the absence or presence of DEX. In bone-marrowderived MSCs that had been cultured in the absence of DEX, BMP-2 stimulated an increase in the deposition of aggrecan, whereas TGF-β1 elicited a barely detectable one. During chondrogenesis, TGFβ/BMP-signaling can also be mediated via "redundant" regulatory pathways, which are controlled by mitogen-activated protein kinases (MAPKs) [such as p38, c-Jun NH 2 -terminal kinase (JNK) and extracellular signal regulated kinase (Erk)] (Miyazono et al., 2001) . Miyazaki et al. have postulated that the inhibitory influence of DEX on the TGF-1-induced growth of rat articular chondrocytes, and their expression of the type-II-collagen gene, may be mediated by its suppression of the activity of the Erk-integrated activator protein-1 (AP-1) (Miyazaki et al., 2000) . However, the molecular mechanisms that govern the infl uence of DEX on the TGF-1-and BMP-2-induced chondrogenesis of MSCs are not precisely known and remain, as yet, a matter for speculation.
Conclusions
In the present study, we have demonstrated the effects of DEX on the chondrogenic differentiation of MSCs to be infl uenced by their microenvironment and tissue origin, as well as by the nature of the growth factor (Fig. 9 ). These fi ndings have an important bearing on cartilageengineering approaches that draw on MSCs of different origins.
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considered to be a specifi c marker of chondrogenesis, for which process it is indispensable. However, expression of the Sox9 gene does not necessarily indicate that a cartilaginous matrix has been deposited. The fi ndings of the present study indicate that the Sox9 gene can be up-regulated even if the genes for other markers of a cartilaginous matrix (collagen types II, IX and XI, aggrecan, COMP and link protein) are down-regulated and if the deposition of type-II collagen and aggrecan are attenuated, as evidenced for synovial explants that had been stimulated with BMP-2 in the presence of DEX. Hence, no single gene can alone be used as a marker of a hyaline type of articular cartilage.
